Indolent Non-Hodgkin Lymphoma — Trials

Indolent Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

791 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 212
Recruiting: 104
Ph III recruiting: 4
Growth YoY: +51.7%
Industry share: 20%
Top sponsor: City of Hope Medical Center
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (150)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06636175	64Cu-LLP2A for Imaging Hematologic Malignancies	recruiting	Early Phase 1	42	Washington University School of MedicineOTHER	1	Jun 17, 2026	clinicaltrials
NCT05838599	Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides	recruiting	Early Phase 1	25	Northwestern UniversityOTHER	1	May 1, 2026	clinicaltrials